Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanling Wu

Showing results (61-70 of 267) with videos related to

Pageof 27
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|October 6, 2025
Novel PD-L1 Small-Molecule Inhibitors Advancing Cancer ImmunotherapyAnnoor Awadasseid, Mengda Wu, Feng Zhang, et al.
Journal of Hazardous Materials|December 3, 2025
Advancing bidirectional hydrogen spillover in heterostructure catalysts for electrocatalytic antimony removal and recovery from wastewaterYuhao Lin, Yanling Wu, Xiaojia Jiang, et al.
Discover Oncology|August 19, 2023
The role of pyroptosis-related lncRNA risk signature in ovarian cancer prognosis and immune systemYanling Wu, Lei Liang, Qin Li, et al.
Peerj|March 25, 2026
A modified homogeneity index for multi- target radiotherapy plans by subtracting high-dose subvolumesYong Sang, Jun Dang, Jianan Wu, et al.
Molecules (Basel, Switzerland)|April 14, 2026
A Contrastive-Learning-Based Pre-Training Framework for Optical Property Prediction of Low-Data Rhodamines with Interpretable Multitask Graph Neural NetworksJiangguo Qiu, Yanling Wu, Hong Zhang, et al.
Annals of the New York Academy of Sciences|September 3, 2021
Determinants associated with doctors' prescribing behaviors in public hospitals in ChinaLihua Pan, Ran Zhao, Nan Zhao, et al.
Emerging Microbes & Infections|April 5, 2022
The prominent role of a CDR1 somatic hypermutation for convergent IGHV3-53/3-66 antibodies in binding to SARS-CoV-2Xiaolong Tian, Xiaoyi Zhu, Wenping Song, et al.
Life Sciences|January 18, 2021
Effect of 4,5-diazafluorene derivative on γδ T cell-mediated cytotoxicity against renal cell carcinomaXiaolan Wen, Yanling Wu, Yoshimasa Tanaka, et al.
Chemmedchem|November 23, 2025
Small-Molecule Inhibitors Targeting PD-1/PD-L1 in Colorectal Cancer: Mechanisms, Challenges, and Clinical ProspectsJianwei Wang, Shenwei Yu, Liang Qian, et al.
The Journal of Gene Medicine|March 30, 2020
A novel UBE2A mutation in a Chinese family with X-linked intellectual disabilityWeimin Jia, Qi Hu, Yanling Wu, et al.
Pageof 27

Showing results (61-70 of 267) with videos related to

Sort By:
Pageof 27
Anti-Cancer Agents in Medicinal Chemistry|October 6, 2025
Novel PD-L1 Small-Molecule Inhibitors Advancing Cancer ImmunotherapyAnnoor Awadasseid, Mengda Wu, Feng Zhang, et al.
Journal of Hazardous Materials|December 3, 2025
Advancing bidirectional hydrogen spillover in heterostructure catalysts for electrocatalytic antimony removal and recovery from wastewaterYuhao Lin, Yanling Wu, Xiaojia Jiang, et al.
Discover Oncology|August 19, 2023
The role of pyroptosis-related lncRNA risk signature in ovarian cancer prognosis and immune systemYanling Wu, Lei Liang, Qin Li, et al.
Peerj|March 25, 2026
A modified homogeneity index for multi- target radiotherapy plans by subtracting high-dose subvolumesYong Sang, Jun Dang, Jianan Wu, et al.
Molecules (Basel, Switzerland)|April 14, 2026
A Contrastive-Learning-Based Pre-Training Framework for Optical Property Prediction of Low-Data Rhodamines with Interpretable Multitask Graph Neural NetworksJiangguo Qiu, Yanling Wu, Hong Zhang, et al.
Annals of the New York Academy of Sciences|September 3, 2021
Determinants associated with doctors' prescribing behaviors in public hospitals in ChinaLihua Pan, Ran Zhao, Nan Zhao, et al.
Emerging Microbes & Infections|April 5, 2022
The prominent role of a CDR1 somatic hypermutation for convergent IGHV3-53/3-66 antibodies in binding to SARS-CoV-2Xiaolong Tian, Xiaoyi Zhu, Wenping Song, et al.
Life Sciences|January 18, 2021
Effect of 4,5-diazafluorene derivative on γδ T cell-mediated cytotoxicity against renal cell carcinomaXiaolan Wen, Yanling Wu, Yoshimasa Tanaka, et al.
Chemmedchem|November 23, 2025
Small-Molecule Inhibitors Targeting PD-1/PD-L1 in Colorectal Cancer: Mechanisms, Challenges, and Clinical ProspectsJianwei Wang, Shenwei Yu, Liang Qian, et al.
The Journal of Gene Medicine|March 30, 2020
A novel UBE2A mutation in a Chinese family with X-linked intellectual disabilityWeimin Jia, Qi Hu, Yanling Wu, et al.
Pageof 27